Guidelines of care for the management of primary cutaneous melanoma

被引:257
作者
Bichakjian, Christopher K. [2 ]
Halpern, Allan C. [3 ]
Johnson, Timothy M. [2 ]
Hood, Antoinette Foote [4 ]
Grichnik, James M. [5 ]
Swetter, Susan M. [6 ,7 ]
Tsao, Hensin [8 ,9 ]
Barbosa, Victoria Holloway [10 ]
Chuang, Tsu-Yi [11 ,12 ]
Duvic, Madeleine [13 ]
Ho, Vincent C. [14 ]
Sober, Arthur J. [8 ,9 ]
Beutner, Karl R. [15 ,16 ]
Bhushan, Reva [1 ]
Begolka, Wendy Smith [1 ]
机构
[1] Amer Acad Dermatol, Schaumburg, IL 60173 USA
[2] Univ Michigan Hlth Syst, Dept Dermatol, Ann Arbor, MI USA
[3] Mem Sloan Kettering Canc Ctr, Dept Dermatol, New York, NY 10021 USA
[4] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA USA
[5] Univ Miami Hosp & Clin, Univ Miami Hlth Syst, Dept Dermatol, Sylvester Comprehens Canc Ctr,Melanoma Program, Miami, FL USA
[6] Stanford Univ, Dept Dermatol, Med Ctr, Stanford, CA 94305 USA
[7] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[8] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
[9] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[10] Rush Univ, Dept Dermatol, Med Ctr, Chicago, IL 60612 USA
[11] Univ So Calif, Los Angeles, CA USA
[12] Desert Oasis Healthcare, Palm Springs, CA USA
[13] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA
[14] Univ British Columbia, Div Dermatol, Vancouver, BC V5Z 1M9, Canada
[15] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[16] Solano Dermatol, Fairfield, CA USA
关键词
biopsy; follow-up; melanoma; pathology report; sentinel lymph node biopsy; surgical margins; SENTINEL LYMPH-NODE; LENTIGO MALIGNA MELANOMA; AMERICAN-JOINT-COMMITTEE; MOHS MICROGRAPHIC SURGERY; UNDERGO COMPLETION LYMPHADENECTOMY; PREDICTING 10-YEAR SURVIVAL; COOPERATIVE-ONCOLOGY-GROUP; RANDOMIZED SURGICAL TRIAL; CANCER STAGING SYSTEM; MM PRIMARY MELANOMA;
D O I
10.1016/j.jaad.2011.04.031
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The incidence of primary cutaneous melanoma has been increasing dramatically for several decades. Melanoma accounts for the majority of skin cancer related deaths, but treatment is nearly always curative with early detection of disease. In this update of the guidelines of care, we will discuss the treatment of patients with primary cutaneous melanoma. We will discuss biopsy techniques of a lesion clinically suspicious for melanoma and offer recommendations for the histopathologic interpretation of cutaneous melanoma. We will offer recommendations for the use of laboratory and imaging tests in the initial workup of patients with newly diagnosed melanoma and for follow-up of asymptomatic patients. With regard to treatment of primary cutaneous melanoma, we will provide recommendations for surgical margins and briefly discuss nonsurgical treatments. Finally, we will discuss the value and limitations of sentinel lymph node biopsy and offer recommendations for its use in patients with primary cutaneous melanoma. (J Am Acad Dermatol 2011;65:1032-47.)
引用
收藏
页码:1032 / 1047
页数:16
相关论文
共 157 条
[1]   Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma [J].
Aloia, Thomas A. ;
Gershenwald, Jeffrey E. ;
Andtbacka, Robert H. ;
Johnson, Marcella M. ;
Schacherer, Christopher W. ;
Ng, Chaan S. ;
Cormier, Janice N. ;
Lee, Jeffrey E. ;
Ross, Merrick I. ;
Mansfield, Paul F. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2858-2865
[2]  
Anderson K W, 2001, Arch Facial Plast Surg, V3, P202, DOI 10.1001/archfaci.3.3.202
[3]  
Armour Katherine, 2005, Australas J Dermatol, V46, P70, DOI 10.1111/j.1440-0960.2005.00144.x
[4]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[5]   Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group [J].
Atkins, Michael B. ;
Hsu, Jessie ;
Lee, Sandra ;
Cohen, Gary I. ;
Flaherty, Lawrence E. ;
Sosman, Jeffrey A. ;
Sondak, Vernon K. ;
Kirkwood, John M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5748-5754
[6]  
Austin JR, 1996, HEAD NECK-J SCI SPEC, V18, P107, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<107::AID-HED1>3.0.CO
[7]  
2-5
[8]  
Australian Cancer Network New Zealand Guidelines Group Cancer Council Australia New Zealand. Ministry of Health, 2008, CLIN PRACT GUID MAN
[9]   Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center [J].
Azzola, MF ;
Shaw, HM ;
Thompson, JF ;
Soong, SJ ;
Scolyer, RA ;
Watson, GF ;
Colman, MH ;
Zhang, YT .
CANCER, 2003, 97 (06) :1488-1498
[10]   Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis [J].
Bafounta, ML ;
Beauchet, A ;
Chagnon, S ;
Saiag, P .
LANCET ONCOLOGY, 2004, 5 (11) :673-680